STSS - Sharps Technology Inc Book Valuation of Business

STSS (Sharps Technology Inc) - company brandmark

Sharps Technology, Inc. (STSS) develops safety syringes, attracting specialists with its mission to ensure healthcare worker safety, which is reflected in the price action at the 0.18 level. The business relies on global sales of high-margin patented blood collection systems. However, current capacity deployment and underutilized production lines are temporarily increasing the cost of goods sold, limiting the company's operating leverage efficiency.

STSS Sharps Tech Book Capitalization (04/28/2023 - 05/28/2026)

Sharps Tech (STSS) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Sharps Technology, Inc.|STSS - Price Target Chart
- market capitalization data:
Market Capitalization Sharps Technology Inc|STSS - Total Company Value
- book capitalization data:
Accounting Value per Share Sharps Technology, Inc.|STSS - Book Capitalization|Market-to-Book Ratio sharpstechnology.com|STSS - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Sharps Technology, Inc.|STSS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Sharps Technology, Inc.|STSS - Company Aggregate Debts|Debt to Book Value Sharps Technology Inc
Fundamental valuation:STSS - Sharps Technology
Mass-produced product of Sharps Technology

Book value capitalization reflects the actual value of the issuer's net assets minus all liabilities. This metric allows an investor to assess the business's intrinsic stability and the risk of overpaying for shares. The trend in book equity visualizes the adaptation of the company's fundamental basis to market conditions. For Sharps Technology, Inc. (STSS), this indicator confirms the financial foundation for developing patented safety systems. However, pressure from industry behemoths may limit the growth of this value.

Competitor analysis for Sharps Technology, Inc.

ISRG: Book Valuation of Business|Danaher Corp. - Company Book Value|BDX (bd.com) - Book Valuation of Business|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|TKNO: Book Valuation of Business|Company Book Value Monogram Orthopedics|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)